Tata India Pharma Healthcare Fund Reg G

Tata India Pharma & Healthcare Fund-Reg(G)

Equity Sectoral - Pharma Rating :

₹ 30.66

NAV
Updated: 09 Jul 2025

Fund House

Fund Manager
Rajat Srivastava
Fund Benchmark
NIFTY PHARMA - TRI
Total AUM
₹ 1,282.00 Cr
Expense Ratio
2.12
52 Week High
₹ 32.01
52 Week Low
₹ 26.57

Fund Verdict

Aggressive Buy

Advance Ratios

P/E Ratio32.01
P/B Ratio5.26
Sharpe0.36
Turnover Ratio15.85
Alpha0.26
Beta0.91
Sortino0.78
Standard Deviation14.15

Fund Performance

Shot Term Returns
Duration 1M 3M 6M 1Y
Returns 4.52% 9.48% -3.56% 14.06%
Long Term Returns
Duration 2Y 3Y 5Y 10Y
Returns 29.50% 25.49% 22.35% -

Market Cap Distribution

  • Large Cap
    41.00 %
  • Mid Cap
    19.10 %
  • Small Cap
    30.74 %
Avg Market Cap
₹ 52,824.00
(In Crore)

Peer Information

Equity Sectoral - Pharma Aggressive Buy
1Y Returns 27.12%
3Y Returns
AUM ₹1,704.90 Cr
NAV ₹17.14
Buy Now
Equity Sectoral - Pharma Aggressive Buy
1Y Returns 20.98%
3Y Returns 30.30%
AUM ₹5,507.50 Cr
NAV ₹40.07
Buy Now
Equity Sectoral - Pharma Aggressive Buy
1Y Returns 21.20%
3Y Returns 27.38%
AUM ₹1,098.70 Cr
NAV ₹290.82
Buy Now
Equity Sectoral - Pharma Aggressive Buy
1Y Returns 16.59%
3Y Returns 26.74%
AUM ₹2,961.40 Cr
NAV ₹39.60
Buy Now

Plan Your Long Term Goals

5,000 per month
Duration
Total investment of ₹0
Would have become ₹0

Ready to explore mutual fund investments? Our experts can help you understand the options, risks, and potential returns to build a financial roadmap tailored to your goals. Schedule a consultation today!

Expert Icon
Talk to an Expert

Mutual Funds Specialist

Expert Icon

Plan Smarter. Invest Better. Retire Happier.

Plan Smarter. Invest Better. Retire Happier